The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...
Discover Microsoft’s holistic SDL for AI combining policy, research, and enablement to help leaders secure AI systems against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results